1. Home
  2. NVO vs LLY Comparison

NVO vs LLY Comparison

Compare NVO & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$45.83

Market Cap

208.2B

Sector

Health Care

ML Signal

HOLD

Logo Eli Lilly and Company

LLY

Eli Lilly and Company

HOLD

Current Price

$1,191.86

Market Cap

979.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVO
LLY
Founded
1923
1876
Country
Denmark
United States
Employees
69500
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.2B
979.6B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
NVO
LLY
Price
$45.83
$1,191.86
Analyst Decision
Hold
Strong Buy
Analyst Count
11
19
Target Price
$51.00
$1,218.84
AVG Volume (30 Days)
10.6M
2.0M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
3.19%
0.81%
EPS Growth
N/A
95.99
EPS
N/A
16.19
Revenue
N/A
$65,179,000,000.00
Revenue This Year
N/A
$27.15
Revenue Next Year
$3.70
$16.04
P/E Ratio
$13.60
$73.68
Revenue Growth
N/A
44.70
52 Week Low
$35.12
$625.90
52 Week High
$64.16
$1,249.45

Technical Indicators

Market Signals
Indicator
NVO
LLY
Relative Strength Index (RSI) 40.53 57.00
Support Level $42.72 $1,032.70
Resistance Level $46.92 $1,240.73
Average True Range (ATR) 1.34 34.58
MACD -0.75 -3.78
Stochastic Oscillator 21.22 78.01

Price Performance

Historical Comparison
NVO
LLY

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About LLY Eli Lilly and Company

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Share on Social Networks: